Perioperative optimization of nutrition leads to lower risks, better outcomes, and improved quality of life for patients.

A retrospective population-based study showed that severe obesity and bariatric surgery independently increased the risk of inflammatory bowel disease.

Administration of semaglutide before metabolic and bariatric surgery does not confer benefits for overall weight loss, ...

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...

Taking a GLP-1 receptor agonist prior to bariatric surgery may not boost long-term weight loss and metabolic benefits, a ...

Actress-comedienne Enot recently dismissed the idea that she had undergone bariatric surgery to achieve her current look, ...

A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...

Struggling to lose weight and concerned about serious health complications? For long-lasting success, consider Ochsner Health ...

Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published online March 5 in JAMA Surgery. Vasundhara ...

Ozempic and similar medications have been hailed as weight loss wonder drugs, but they don't work for everyone and can have ...

A new study finds that ursodeoxycholic acid (UDCA) effectively dissolves gallstones in 60% of patients after sleeve ...

A study by Mass General Brigham found that taking the weight-loss drug semaglutide before bariatric surgery does not lead to ...